What is MicroFour?
MicroFour operates as a specialized software provider with a deep-rooted history spanning over three decades in the medical technology landscape. The company is primarily recognized for its comprehensive suite of electronic health records and practice management solutions, including its flagship products PracticeStudio and RxWriter. By integrating .NET application frameworks with specialized clinical management tools, MicroFour delivers high-compliance, reliable infrastructure designed to streamline workflows for medical clinics and healthcare providers. Their market position is fortified by a commitment to e-prescribing efficiency and rigorous certification standards, ensuring that their software remains a critical component of modern healthcare operations.
How much funding has MicroFour raised?
MicroFour has raised a total of $418K across 2 funding rounds:
Debt
$150K
Debt
$268K
Debt (2020): $150K with participation from PPP
Debt (2021): $268K led by PPP
Key Investors in MicroFour
PPP
Public-Private Partnership
What's next for MicroFour?
With this late-stage capital injection, MicroFour is well-positioned to accelerate its product development lifecycle and expand its footprint in the digital health ecosystem. The strategic allocation of these funds will likely focus on enhancing the interoperability of their existing software frameworks and scaling their consulting services to meet the evolving regulatory demands of the healthcare industry. As the firm transitions into this next phase of growth, the focus remains on leveraging its extensive domain expertise to drive innovation in clinic management, ensuring that their technological offerings continue to provide high-value outcomes for medical practitioners and administrative stakeholders alike.
See full MicroFour company page
